NTRK2 and cancer: Among these mechanisms, the Tyrosine Receptor Kinase B and Brain Derived neurotropic Factor (TrkB/BDNF) system has been reported to be responsible for chemoresistance, through Akt/PI-3K and MAPK signaling pathways, in selected models of cancer [7], [8].